{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:09:29Z","timestamp":1785881369347,"version":"3.56.0"},"reference-count":23,"publisher":"Frontiers Media SA","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2421,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1111\/j.1432-2277.2008.00831.x","type":"journal-article","created":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T16:20:46Z","timestamp":1231950046000},"page":"562-567","source":"Crossref","is-referenced-by-count":37,"title":["Pegylated interferon-\u03b1-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study"],"prefix":"10.3389","volume":"22","author":[{"given":"Georges-Philippe","family":"Pageaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Noelle","family":"Hilleret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Garrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bismuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9la","family":"Audin-Mamlouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Zarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2009,1,14]]},"reference":[{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ki.1997.139","article-title":"Hepatitis C virus infection in dialysis and renal transplantation","volume":"51","author":"Pereira","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2036.2005.02662.x","article-title":"Review article: hepatitis C virus and calcineurine inhibition after renal transplantation","volume":"25","author":"Fabrizi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 10","key":"10.1111\/j.1432-2277.2008.00831.x-BIB3|cit3","first-page":"72","article-title":"Viral Hepatitis guidelines in hemodialysis and transplantation","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/00007890-199811150-00023","article-title":"Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation : response to interferon-alpha therapy","volume":"66","author":"Toth","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0272-6386(03)00422-0","article-title":"Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology","volume":"42","author":"Kamar","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.TP.0000128911.87538.AA","article-title":"Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C","volume":"78","author":"Fontaine","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jcv.2003.10.001","article-title":"Amantadine therapy in renal transplant patients with hepatitis C virus infection","volume":"30","author":"Kamar","year":"2004","journal-title":"J clin virol"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1365-2036.2006.03151.x","article-title":"Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00007890-199409150-00018","article-title":"Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study","volume":"58","author":"Thervet","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00007890-199504150-00030","article-title":"Interferon-alpha-induced acute renal allograft rejection","volume":"59","author":"Magnone","year":"1995","journal-title":"Transplantation"},{"issue":"Suppl. 6","key":"10.1111\/j.1432-2277.2008.00831.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ndt\/10.supp6.93","article-title":"Preliminary results of treatment of chronic hepatitis C with recombinant interferon-alpha in renal transplant patients","volume":"10","author":"Rostaing","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/S0041-1345(99)00603-X","article-title":"Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C","volume":"31","author":"Tokumoto","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-6143.2003.30113.x","article-title":"Acute tumoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy","volume":"3","author":"Baid","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1053\/ajkd.2000.8302","article-title":"Renal thrombotic microangiopathy associated with interferon-alpha treatment of chronic myeloid leukemia","volume":"36","author":"Magee","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1053\/ajkd.2003.50137","article-title":"Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha","volume":"41","author":"Ohashi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/1042819021000055066","article-title":"Vascular events associated with alpha interferon therapy","volume":"44","author":"Al-Zahrani","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0151-9638(07)88994-0","article-title":"Haemolytic uremic syndrome and acute mesenteric ischemia caused by interferon-alpha-2b in the treatment of Kaposi\u2019s sarcoma in an AIDS patient","volume":"134","author":"Zaraa","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1432-2277.1996.tb00855.x","article-title":"Hemolytic uremic syndrome in solid-organ transplant recipient","volume":"9","author":"Singh","year":"1996","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2893.2001.00271.x","article-title":"Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in na\u00efve patients: 1999 update","volume":"8","author":"Th\u00e9venot","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM200012073432301","article-title":"Peginterferon alpha-2a in patients with chronic hepatitis C","volume":"343","author":"Zeuzem","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/jhep.2001.26371","article-title":"A randomized, double-blind trial comparing pegylated interferon-alpha-2b to interferon-alpha-2b as initial treatment for chronic hepatitis C","volume":"34","author":"Lindsay","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/009127002401382713","article-title":"Single-dose pharmacokinetics and safety of pegylated interferon-alpha2b in patients with chronic renal dysfunction","volume":"42","author":"Gupta","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1432-2277.2008.00831.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.565","article-title":"Hepatitis C virus infection in haemodialysis and kidney transplant patients","volume":"18","author":"Baid-Agrawal","year":"2008","journal-title":"Rev Med Virol"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2008.00831.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2008.00831.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:38:55Z","timestamp":1641062335000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2008.00831.x"}},"subtitle":["Pegylated interferon-\u03b1 for chronic hepatitis C in renal transplant recipients"],"short-title":[],"issued":{"date-parts":[[2009,1,14]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00831.x","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,14]]}}}